Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.890

+2.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shlepper who wrote (109)	3/8/1998 11:48:00 AM
From: WWS	Read Replies (1) of 233

Shep, I'm considering a modest investment in MAGN, and have read the thread. I noticed, too, that MAGN was mentioned last week in TheStreetCom, with pointers to the two George Stassen articles our previous poster was kind enough to provide, and that MAGN is one of the holdings in Smart Money Magazine's "growth" portfolio (altho not a profitable pick so far). On the 17th I'm going to hear a seminar on antibiotic peptides at Washington U. here in STL by Magainin's Mike Zasloff. Assuming that there'll be time to ask just one question of him, what would be the most important question to ask? Would it be "when will the NDA on Cytolex be submitted?" Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next